Companion Diagnostics Market Global Industry Insights, and Opportunity Analysis – 2024

1
(No Transcript)
2

• REPORT DESCRIPTION

Global Companion Diagnostics Market
Overview Personalized medicine is the new segment
in discussion among healthcare experts around the
globe. Also, encouragement from the regulatory
bodies such as the FDA and EMEA in erms of
providing a defined structure for companion
diagnostic development is driving research
activities in personalized medicine. Diagnosis at
molecular level for each individual is of prime
importance to identify the target biomarker
before deciding the therapy. Companion diagnostic
is one such emerging field for target biomarker
identification reducing clinical trial cost and
time to market the product. Pharmaceutical
companies need to constantly innovate and
integrate latest technological breakthroughs in
order to sustain in the companion diagnostics
market, given the looming threat of new
technologies posing threat to existing product
portfolio and research pipeline. Novartis AG
focuses on RD for biomarkers with the help of
its partner SomaLogic, Inc., once they begin the
process of finalizing the drug candidate. Such
pre-work is now part of the routine of drug
development, something that was an alien practice
till around a decade ago. The U.S. FDA released a
draft guideline for companion diagnostics in July
2016, providing a structure for the
pharmaceutical companies to co-develop CDx test
along with the drug therapies. The global
companion diagnostics market was valued at US
1,614.5 million in 2015 and is expected to
witness a robust CAGR of 12.0 during the
forecast period (2016 2024).
3
REPORT DESCRIPTION

• Global Companion Diagnostics Market Taxonomy
• Global Companion Diagnostics Market, By
  Application
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Gastric Cancer
• Melanoma
• Others
• Global Companion Diagnostics Market, By
  Technology
• Immunohistochemistry
• Real-time PCR
• Gene Sequencing
• FISH
• Others
• Request report sample for more professional and
  technical insights https//www.coherentmarketinsi
  ghts.com/insight/request-sample/109

4
REPORT DESCRIPTION

• Global Companion Diagnostics Market Taxonomy
• Global Companion Diagnostics Market, By
  Geography
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East
• Africa
• Click here to know more about this publish
  report https//www.coherentmarketinsights.com/mar
  ket-insight/companion-diagnostics-market-109

5
REPORT DESCRIPTION

• Global Companion Diagnostics Market Key Players
• Major players involved in the global companion
  diagnostics market include
• Abbott Laboratories, Inc.
• Agilent Technologies, Inc.
• Danaher Corporation
• GE Healthcare
• Qiagen N.V.
• Roche Diagnostics
• Myriad Genetics, Inc.
• bioMérieux SA
• Illumina, Inc.
• Siemens Healthcare

6
(No Transcript)
7
(No Transcript)
8
(No Transcript)
9
THANK YOU
To know more about us, visit our website
www.coherentmarketinsights.com For sales
queries or new topics email us on
sales_at_coherentmarketinsights.com For other
queries contact Mr. Shah (Manager - Business Deve
lopment) Coherent Market Insights sales_at_coherentm
arketinsights.com 1-206-701-6702